rs118089506

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_032444.4(SLX4):​c.90C>T​(p.Ser30Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00833 in 1,614,138 control chromosomes in the GnomAD database, including 70 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0062 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 66 hom. )

Consequence

SLX4
NM_032444.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 2.52
Variant links:
Genes affected
SLX4 (HGNC:23845): (SLX4 structure-specific endonuclease subunit) This gene encodes a protein that functions as an assembly component of multiple structure-specific endonucleases. These endonuclease complexes are required for repair of specific types of DNA lesions and critical for cellular responses to replication fork failure. Mutations in this gene were found in patients with Fanconi anemia. [provided by RefSeq, Sep 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 16-3608875-G-A is Benign according to our data. Variant chr16-3608875-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 241701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-3608875-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=2.52 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00619 (943/152252) while in subpopulation AMR AF= 0.0098 (150/15300). AF 95% confidence interval is 0.00885. There are 4 homozygotes in gnomad4. There are 447 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLX4NM_032444.4 linkc.90C>T p.Ser30Ser synonymous_variant Exon 2 of 15 ENST00000294008.4 NP_115820.2 Q8IY92-1
SLX4XM_024450471.2 linkc.90C>T p.Ser30Ser synonymous_variant Exon 2 of 15 XP_024306239.1
SLX4XM_011522715.4 linkc.90C>T p.Ser30Ser synonymous_variant Exon 2 of 15 XP_011521017.1
SLX4XR_007064923.1 linkn.739C>T non_coding_transcript_exon_variant Exon 2 of 13

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLX4ENST00000294008.4 linkc.90C>T p.Ser30Ser synonymous_variant Exon 2 of 15 5 NM_032444.4 ENSP00000294008.3 Q8IY92-1
SLX4ENST00000466154.5 linkn.385C>T non_coding_transcript_exon_variant Exon 1 of 7 1
SLX4ENST00000486524.1 linkn.718C>T non_coding_transcript_exon_variant Exon 2 of 4 2
SLX4ENST00000697859.1 linkn.712C>T non_coding_transcript_exon_variant Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.00621
AC:
945
AN:
152134
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00982
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00788
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00945
Gnomad OTH
AF:
0.0110
GnomAD3 exomes
AF:
0.00604
AC:
1520
AN:
251472
Hom.:
6
AF XY:
0.00661
AC XY:
898
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00523
Gnomad ASJ exome
AF:
0.00397
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00670
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.00898
Gnomad OTH exome
AF:
0.00684
GnomAD4 exome
AF:
0.00855
AC:
12495
AN:
1461886
Hom.:
66
Cov.:
31
AF XY:
0.00871
AC XY:
6335
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.00134
Gnomad4 AMR exome
AF:
0.00579
Gnomad4 ASJ exome
AF:
0.00409
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00718
Gnomad4 FIN exome
AF:
0.000618
Gnomad4 NFE exome
AF:
0.00981
Gnomad4 OTH exome
AF:
0.00803
GnomAD4 genome
AF:
0.00619
AC:
943
AN:
152252
Hom.:
4
Cov.:
32
AF XY:
0.00600
AC XY:
447
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.00157
Gnomad4 AMR
AF:
0.00980
Gnomad4 ASJ
AF:
0.00375
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.00747
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00945
Gnomad4 OTH
AF:
0.0109
Alfa
AF:
0.00755
Hom.:
4
Bravo
AF:
0.00641
Asia WGS
AF:
0.00606
AC:
21
AN:
3478
EpiCase
AF:
0.0110
EpiControl
AF:
0.0120

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group P Benign:4
Jul 26, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Jan 05, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SLX4: BP4, BP7, BS2 -

Sep 22, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 22383991) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:2
Jan 11, 2021
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 31, 2012
Leiden Open Variation Database
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: curation

Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker. -

Fanconi anemia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 28, 2020
Sema4, Sema4
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.8
DANN
Benign
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs118089506; hg19: chr16-3658876; API